Gadavist (Bayer HealthCare Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Gadavist drug offered from Bayer HealthCare Pharmaceuticals Inc.. This Gadolinium-based Contrast Agent [EPC],Magnetic Resonance Contrast Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Bayer HealthCare Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | gadobutrol |
| SUBSTANCE NAME: | GADOBUTROL |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Gadolinium-based Contrast Agent [EPC],Magnetic Resonance Contrast Activity [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2011-03-14 |
| END MARKETING DATE: | 0000-00-00 |
Gadavist HUMAN PRESCRIPTION DRUG Details:
| Item Description | Gadavist from Bayer HealthCare Pharmaceuticals Inc. |
| LABELER NAME: | Bayer HealthCare Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 604.72(mg/mL) |
| START MARKETING DATE: | 2011-03-14 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 50419-325_f613ff35-06d2-469a-89c2-88a132ed3b8c |
| PRODUCT NDC: | 50419-325 |
| APPLICATION NUMBER: | NDA201277 |
Other GADOBUTROL Pharmaceutical Manufacturers / Labelers:
